Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Cardiac amyloidosis is a form of restrictive infiltrative cardiomyopathy that confers significant
mortality. Due to the relative rarity of cardiac amyloidosis, clinical and diagnostic expertise in …

Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …

After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema,
inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and …

In cardiac magnetic resonance (CMR) imaging, the T1 relaxation time for the 1H
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …

Objectives: Cardiac magnetic resonance (CMR) was used to investigate the extracellular
compartment and myocardial fibrosis in patients with aortic stenosis, as well as their …

The longitudinal relaxation time constant (T1) of the myocardium is altered in various
disease states due to increased water content or other changes to the local molecular …

Magnetic resonance (MR) studies suggested cardiac involvement post‐Covid‐19 in a
significant subset of affected individuals, including athletes. This brings serious clinical …

Abstract Background: The HCMR (Hypertrophic Cardiomyopathy Registry) is a National
Heart, Lung, and Blood Institute–funded, prospective registry of 2,755 patients with …

With mounting data on its accuracy and prognostic value, cardiovascular magnetic
resonance (CMR) is becoming an increasingly important diagnostic tool with growing utility …